Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia
Miguel Alejandro Pinzón, Santiago Ortiz, Héctor Holguín, et al.
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0252057-e0252057
Open Access | Times Cited: 178

Showing 1-25 of 178 citing articles:

Potential therapeutic options for COVID-19: an update on current evidence
Zahra Niknam, Ameneh Jafari, Ali Golchin, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 136
Two Years into the COVID-19 Pandemic: Lessons Learned
Severino Jefferson Ribeiro da Silva, Jéssica Catarine Frutuoso do Nascimento, Renata Pessôa Germano Mendes, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 9, pp. 1758-1814
Open Access | Times Cited: 103
Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 78
The relationship between steroid treatment and mortality in patients with COVID-19 followed up in an intensive care unit
Huseyin Ali Ozturk, Fatih Necip Arıcı
PeerJ (2025) Vol. 13, pp. e18606-e18606
Open Access | Times Cited: 1
High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome: A Multicenter, Randomized Open-Label Clinical Trial
Luis Patricio Maskin, Ignacio Bonelli, Gabriel Leonardo Olarte, et al.
Journal of Intensive Care Medicine (2021) Vol. 37, Iss. 4, pp. 491-499
Open Access | Times Cited: 60
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19
Matthew G. Johnson, Amy Puenpatom, Pablo Andrés Moncada, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 8, pp. 1126-1134
Open Access | Times Cited: 55
The Relationship between COVID-19 and Hypothalamic–Pituitary–Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess—The CAPISCO International Expert Panel
Mojca Jensterle, Rok Herman, Andrej Janež, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7326-7326
Open Access | Times Cited: 50
Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial
Negar Toroghi, Ladan Abbasian, Anahid Nourian, et al.
Pharmacological Reports (2021) Vol. 74, Iss. 1, pp. 229-240
Open Access | Times Cited: 52
Consensus and Controversial Aspects of Vitamin D and COVID-19
John P. Bilezikian, Neil Binkley, Hector F De Luca, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 5, pp. 1034-1042
Open Access | Times Cited: 31
Role of Dexamethasone and Methylprednisolone Corticosteroids in Coronavirus Disease 2019 Hospitalized Patients: A Review
Jyoti Mehta, Rajan Rolta, Brij Bhushan Mehta, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 28
Mouse models of COVID-19 recapitulate inflammatory pathways rather than gene expression
Cameron Bishop, Troy Dumenil, Daniel J. Rawle, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 9, pp. e1010867-e1010867
Open Access | Times Cited: 27
Predictive models of long COVID
Blessy Antony, Hannah Blau, Elena Casiraghi, et al.
EBioMedicine (2023) Vol. 96, pp. 104777-104777
Open Access | Times Cited: 20
Corticosteroids in COVID-19: pros and cons
Aymen Bahsoun, Yeva Fakih, Rana Zareef, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 16
Efficacy of different doses of corticosteroids in treating severe COVID-19 pneumonia
Ge zhang, Lin Su, Wenwen Wu, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Immunobiology and immunotherapy of COVID-19
Kenneth Lundström
Progress in molecular biology and translational science (2025)
Closed Access
Factors associated with glucocorticoid dosing in treating patients with noncritical COVID-19 pneumonia: Insights from an artificial intelligence-based CT imaging analysis
Jie Wang, Chang He, Yu Shi, et al.
Enfermedades Infecciosas y Microbiología Clínica (2025)
Closed Access
Inflammatory Biomarkers Demonstrate Predictive Capacity for Mortality in COVID-19-Related ARDS Patients Receiving High-Dose Corticosteroids: A Longitudinal Analysis
Katrijn Daenen, Anders Boyd, Jilske Huijben, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 2395-2408
Open Access
PEGylated green halloysite/spinel ferrite nanocomposites for pH sensitive delivery of dexamethasone: A potential pulmonary drug delivery treatment option for COVID-19
B. Rabindran Jermy, Vijaya Ravinayagam, Dana Almohazey, et al.
Applied Clay Science (2021) Vol. 216, pp. 106333-106333
Open Access | Times Cited: 32
Endocrine Follow-up During Post-Acute COVID-19: Practical Recommendations Based on Available Clinical Evidence
Rimesh Pal, Ameya Joshi, Sanjay Kumar Bhadada, et al.
Endocrine Practice (2022) Vol. 28, Iss. 4, pp. 425-432
Open Access | Times Cited: 25
High-Dose versus Low-Dose Corticosteroids in COVID-19 Patients: a Systematic Review and Meta-analysis
Rachel Si Jing Tan, Ka Ting Ng, Chua Ee Xin, et al.
Journal of Cardiothoracic and Vascular Anesthesia (2022) Vol. 36, Iss. 9, pp. 3576-3586
Open Access | Times Cited: 24
A systematic review and meta-analysis of glucocorticoids treatment in severe COVID-19: methylprednisolone versus dexamethasone
Shukun Hong, Hongye Wang, Shuyuan Li, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
CCR5/CXCR3 antagonist TAK-779 prevents diffuse alveolar damage of the lung in the murine model of the acute respiratory distress syndrome
А. С. Чернов, Maksim V. Rodionov, В. А. Казаков, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Dexamethasone in COVID-19 treatment: Analyzing monotherapy and combination therapy approaches
Seyed Mohammadmahdi Meybodi, Venus Shahabi Rabori, Darya Salkhorde, et al.
Cytokine (2024) Vol. 184, pp. 156794-156794
Closed Access | Times Cited: 4
Double Trouble—COVID-19 and the Widespread Use of Corticosteroids: Are We Staring at an Osteonecrosis Epidemic?
Gautam M. Shetty
Indian Journal of Orthopaedics (2021) Vol. 56, Iss. 2, pp. 226-236
Open Access | Times Cited: 29
Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?
Kavya Srinivasan, Ashutosh Pandey, Ashlena Livingston, et al.
Molecular Biomedicine (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top